Hone Health announced a strategic integration of Prenuvo’s whole-body MRI scans into its personalized longevity care platform, according to the company. The partnership brings together Hone’s hormone and metabolic data-centric telehealth services with Prenuvo’s advanced diagnostic imaging, enabling users to access comprehensive health insights and clinician-guided care within a unified ecosystem.
The company said that Prenuvo’s whole-body MRI scan captures millions of data points in under an hour and has previously flagged potentially life-saving findings in approximately one in 20 scans. Hone claims this integration enables a proactive care model where users can transition seamlessly from screening to personalized treatment plans without delays.
Hone said the initiative is part of its broader ambition to evolve into a “Personalized OS for Longevity,” merging diagnostics, AI-driven data analysis, and individualized care within a single digital platform. According to Hone, the partnership addresses a critical gap in traditional healthcare by shifting the focus from reactive treatment to proactive, personalized prevention.
The company claimed that through this combined offering, clients will benefit from early detection of conditions such as solid tumors, metabolic disorders, brain aneurysms, autoimmune disorders, and spinal degeneration—all areas included in Prenuvo’s whole-body scan coverage. Hone highlighted that screening and actionable insights are enabled through a direct booking process via its app, followed by radiologist review and clinician consultation.
Hone additionally said that the collaboration supports its mission of making advanced longevity diagnostics and care more accessible and integrated, enabling users to achieve improved healthspan outcomes through early intervention and coordinated care pathways.
